We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.36B
AUM Growth
-$1.11B
(-12%)
Cap. Flow
-$2.9B
Cap. Flow
% of AUM
-34.73%
Top 10 Holdings %
Top 10 Hldgs %
14.55%
Holding
1,631
New
393
Increased
241
Reduced
303
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$83.4M |
| 2 |
Trip.com Group
TCOM
|
+$77.5M |
| 3 |
Expedia Group
EXPE
|
+$77.4M |
| 4 |
FirstEnergy
FE
|
+$56M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$53.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$89.1M |
| 2 |
Booking.com
BKNG
|
+$62.6M |
| 3 |
Abbott
ABT
|
+$56.3M |
| 4 |
AbbVie
ABBV
|
+$55.7M |
| 5 |
Teradata
TDC
|
+$54.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 10.06% |
| 2 | Technology | 8.16% |
| 3 | Communication Services | 7.9% |
| 4 | Consumer Staples | 7.67% |
| 5 | Healthcare | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
PUT
Ross Stores
ROST
$81.1B
| $420K | 0.01% |
+11,200
| New | +$421K |
|
|
EGN
652
DELISTED
Energen
EGN
| $419K | 0.01% |
+5,922
| New | +$445K |
|
653
CALL
Alnylam Pharmaceuticals
ALNY
$29.5B
| $418K | 0.01% |
6,500
+200
| +3% | +$11.9K |
|
654
Coeur Mining
CDE
$16B
| $417K | 0.01% |
38,444
-234,325
| -86% | -$2.64M |
|
655
Fossil Group
FOSL
$348M
| $417K | 0.01% |
3,478
-32,819
| -90% | -$4.05M |
|
656
Edgewell Personal Care
EPC
$1.27B
| $412K | ﹤0.01% |
5,130
-87,084
| -94% | -$6.63M |
|
657
CALL
RTX Corp
RTX
$292B
| $410K | ﹤0.01% |
+5,720
| New | +$390K |
|
|
MKTO
658
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $407K | ﹤0.01% |
10,996
-3,609
| -25% | -$119K |
|
659
Neurocrine Biosciences
NBIX
$16.7B
| $406K | ﹤0.01% |
+43,452
| New | +$424K |
|
660
World Acceptance Corp
WRLD
$877M
| $404K | ﹤0.01% |
+4,609
| New | +$430K |
|
|
CHK
661
DELISTED
Chesapeake Energy Corporation
CHK
| $404K | ﹤0.01% |
79
-274
| -78% | -$1.39M |
|
662
PUT
Visa
V
$683B
| $403K | ﹤0.01% |
+7,200
| New | +$363K |
|
663
Petrobras Class A
PBR.A
$109B
| $401K | ﹤0.01% |
+27,291
| New | +$449K |
|
664
Herbalife
HLF
$1.32B
| $400K | ﹤0.01% |
+10,162
| New | +$352K |
|
665
CALL
Zimmer Biomet
ZBH
$18.8B
| $400K | ﹤0.01% |
4,429
-1,648
| -27% | -$143K |
|
|
MOVE
666
CALL
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
| $400K | ﹤0.01% |
+25,000
| New | +$408K |
|
667
CALL
Mercado Libre
MELI
$96.3B
| $398K | ﹤0.01% |
+3,700
| New | +$443K |
|
668
PUT
Tractor Supply
TSCO
$16.8B
| $395K | ﹤0.01% |
+25,500
| New | +$364K |
|
669
PUT
Western Digital
WDC
$182B
| $395K | ﹤0.01% |
6,218
-794
| -11% | -$44.4K |
|
|
EGN
670
CALL
DELISTED
Energen
EGN
| $395K | ﹤0.01% |
+5,600
| New | +$421K |
|
|
SIAL
671
PUT
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $394K | ﹤0.01% |
4,200
+900
| +27% | +$78.2K |
|
|
YHOO
672
DELISTED
Yahoo Inc
YHOO
| $393K | ﹤0.01% |
+9,709
| New | +$348K |
|
|
ELLI
673
CALL
DELISTED
Ellie Mae Inc
ELLI
| $392K | ﹤0.01% |
14,600
-11,300
| -44% | -$318K |
|
|
NILE
674
CALL
DELISTED
Blue Nile, Inc.
NILE
| $391K | ﹤0.01% |
8,300
+1,800
| +28% | +$77.9K |
|
675
PUT
Procter & Gamble
PG
$338B
| $390K | ﹤0.01% |
+4,800
| New | +$391K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Highbridge Capital Management held 1,631 positions worth $8.36B, down 12% from $9.47B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Highbridge Capital Management withdrew a net $2.9B in Q4 2013, closing 606 positions and reducing 303 holdings. Its most notable exit was AbbVie, an estimated $55.7M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 10% of assets, up from 9% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Highbridge Capital Management opened a new position in Quest Diagnostics worth $43.3M.
- Highbridge Capital Management's largest Q4 2013 buy was Quest Diagnostics: 809,031 shares worth $43.3M.
- Highbridge Capital Management added most to Apple in Q4 2013, an estimated $83.4M increase.
- Highbridge Capital Management's biggest Q4 2013 reduction was VMware, Inc, cutting an estimated $89.1M.
- Highbridge Capital Management fully exited AbbVie in Q4 2013, selling an estimated $55.7M.
- Highbridge Capital Management's ten largest holdings make up 15% of its $8.36B portfolio in Q4 2013.
- Highbridge Capital Management opened 393 new positions and closed 606 in Q4 2013.
- Highbridge Capital Management's portfolio value fell 12% quarter-over-quarter to $8.36B.
Based on Highbridge Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.